Efficiency of radioactive I-131 therapy in geriatric patients with toxic nodular goiter

Aging Clinical and Experimental Research

Volumn 24, Issue 6, 2012, Pages 714-717

  Erkan, Melih Engin ^a   Demirin, Hilmi ^a   Aşik, Muhammed ^a   Celbek, Gökhan ^a   Yildirim, Mustafa ^a   Aydin, Yusuf ^a   Güngör, Adem ^a   Doǧan, Ahmet Semih ^a  

^a DUZCE UNIVERSITY   (Turkey)

Author keywords

Geriatrics; Hyperthyroidism; Iodine radioisotopes; Thyroid nodule

Indexed keywords

IODINE 131; PROPYLTHIOURACIL;

ADULT; AGED; ARTICLE; EUTHYROIDISM; FEMALE; FOLLOW UP; GERIATRIC PATIENT; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; THYROTOXICOSIS; TOXIC GOITER;

AGED; FEMALE; GOITER, NODULAR; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; THYROTOXICOSIS; TREATMENT OUTCOME;

EID: 84876934225     PISSN: 15940667     EISSN: 17208319     Source Type: Journal    
DOI: 10.3275/8759     Document Type: Article

References (27)

1. Franklyn JA. The management of hyperthyroidism. N Engl J Med 1994; 330(24): 1731-8. (Pubitemid 124005036)
2. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 1997; 7: 481-93.
3. Laurberg P, Pedersen KM, Vestergaard H, Sigurdsson G. High incidence of multinodular toxic goitre in the elderly population in a low iodine intake area vs. high incidence of Graves' disease in the young in a high iodine intake area: comparative surveys of thyrotoxicosis epidemiology in East-Jutland Denmark and Iceland. J Intern Med 1991; 229: 415-20.
4. Erdoǧan MF, Atli T, Ekinci C, Genç Y, Gökmen H, Erdoǧan G. Orta derecede iyot eksikliǧi olan bir bölgede yasayan yaşlilardaki tiroid hastaliklari spektrumu ve prevelansi. Turkish Journal of Geriatrics 2002; 5 (2): 49-53.
5. Ustun F, Yuksel M, Durmus-Altun G, Kaya M, Cermik TF, Sarikaya A, et al. The incidence of recurrence and hypothyroidism after radioiodine treatment in patients with hyperthyroidism in Trakya, a mild iodine deficiency area, during the period 1991-2003. Ann Nucl Med. 2005; 19(8):737-42. (Pubitemid 43175538)
6. Assey VD, Greiner T, Mzee RK, Abuu H, Mgoba C, Kimboka S, et al. Iodine defi ciency persists in the Zanzibar Islands of Tanzania. Food Nutr Bull 2006; 27: 292-99. (Pubitemid 46023834)
7. Zimmermann MB, Jooste PL, Pandav CS. Iodine-deficiency disorders. Lancet. 2008; 372 (9645): 1251-62.
8. Mosekilde L, Eriksen EF, Charles P. Effects of thyroid hormones on bone and mineral metabolism. Endocrinol Metab Clin North Am. 1990; 19: 35- 62.
9. Cobler JL, Williams ME, Greenland P. Thyrotoxicosis in institutionalized elderly patients with atrial fibrillation. Arch Intern Med 1984; 144: 1758-60. (Pubitemid 14070028)
10. Trivalle C, Doucet J, Chassagne P, Landrin I, Kadri N, Menard JF, et al. Differences in the Signs and Symptoms of Hyperthyroidism in Older and Younger Patients. J Am Geriatr Soc 1996; 44: 50-53. (Pubitemid 26017766)
11. Ronnov-Jessen V, Kirkegaard C. Hyperthyroidism: a disease of old age? BMJ 1973; 1: 41-43.
12. Cooper DS. Antithyroid drugs. N Engl J Med 2005; 352: 905-17. (Pubitemid 40300299)
13. Jain K, Chakrapani M, Smitha K. Acute cholestatic hepatitis along with agranulocytosis: a rare side effect of carbimazole. Ann Afr Med. 2010; 9(2):102-4.
14. Vilchez FJ, Torres I, Garcia-Valero A, Lσpez-Tinoco C, de Los Santos A, Aguilar-Diosdado M. Concomitant agranulocytosis and hepatotoxicity after treatment with carbimazole. Ann Pharmacother 2006; 40: 2059-63. (Pubitemid 44747480)
15. Clerc J, Dagousset F, Izembart M, Jais JP, Heshmati HM, Alcaïs A, et al. Radioiodine therapy of the autonomous thyroid nodule in patients with and without visible extranodular activity. J Nucl Med 1995; 36: 217-223.
16. Van Soestbergen MJM, Van der Vijver JCM, Graafland AD. Recurrence of hyperthyroidism in multinodular goiter after long-term drug therapy: a comparison with Graves' disease. J Endocrinol Invest 1992; 15: 797-800. (Pubitemid 23060029)
17. Hoekstra HJ. Cancer surgery in the elderly. Eur J Cancer 2001; 37:Suppl.7: 235-44.
18. Türkmen A, Turgut N. Geriatrik anestezi. Turkish Journal of Geriatrics 2007; 10 (1): 49-56.
19. Tarantini B, Ciuoli C, Di Cairano G, Guarino E, Mazzucato P, Montanaro A, et al. Effectiveness of radioiodine (131-I) as definitive therapy in patients with autoimmune and non-autoimmune hyperthyroidism. J Endocrinol Invest. 2006; 29(7): 594-8. (Pubitemid 44446268)
20. Reiners C, Schneider P. Radioiodine therapy of thyroid autonomy. Eur J Nucl Med Mol Imaging. 2002; 29 Suppl 2:471-8.
21. Çinar N,Gürlek A. The Reliability of Radioiodine Treatment in the Long Term. Turkiye Klinikleri J Endocrin-Special Topics 2008;1(3):71-8.
22. Luster M, Verburg FA, Scheidhauer K. Diagnostic imaging work up in multi-nodular goiter. Minerva Endocrinol. 2010 Sep;35(3):153-9.
23. Okosieme OE, Chan D, Price SA, Lazarus JH, Premawardhana LD. The utility of radioiodine uptake and thyroid scintigraphy in the diagnosis and management of hyperthyroidism.Clin Endocrinol (Oxf). 2010; 72(1):122-7.
24. Allahabadia A, Daykin J, Sheppard MC, Gough SC, Franklyn JA. Radioiodine treatment of hyperthyroidism-prognostic factors for outcome. J Clin Endocrinol Metab. 2001; 86(8): 3611-7. (Pubitemid 32755951)
25. Hancock LD, Tuttle RM, LeMar H, Bauman J, Patience T. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease. Clinical Endocrinology 1997; 47: 425-430. (Pubitemid 27452061)
26. Imseis RE, Vanmiddlesworth L, Massie JD, Bush AJ, Vanmiddlesworth NR. Pretreatment with propylthiouracil but not methimazole reduces the therapeutic efficacy of iodine-131 in hyperthyroidism. Journal of Clinical Endocrinology and Metabolism 1998; 83: 685-687. (Pubitemid 28496558)
27. 131I treatment of hyperthyroidism. Thyroidology Clin Exp. 1997; 9: 55-59.